Dianne Parrotte Biography and Net Worth

Director of Cognex


Dr. Dianne M. Parrotte M.D. serves as Independent Director of the Company. Dr. Parrotte has served as a director since 2018. Since 1995, Dr. Parrotte has been an independent consultant to corporations, law firms and insurance companies on human resource matters involving employee health and wellness. She was a trustee of the Shillman Foundation from March 2000 until her resignation in February 2018. From 1989 until 1995, Dr. Parrotte was chief in charge of occupational health at Bath Iron Works (later acquired by General Dynamics). From 1982 to 1988, she was the on-site medical director at Polaroid Corporation. Dr. Parrotte served as a Cognex director from 1981, at the time of the Company’s incorporation, to 1982. In addition to numerous certifications and licenses, Dr. Parrotte holds an M.P.H. from the Medical College of Wisconsin, an M.D. from the Boston University School of Medicine and a B.A. from Boston University. She also completed the Penn State Executive Program. During the past five years, Dr. Parrotte has not served as a member of the Board of Directors of another publicly held company or of a registered investment company. Parrotte’s qualifications for sitting on our Board of Directors include her experience with a wide range of human resource and organizational matters, as well as her significant knowledge of the history and culture of Cognex.

What is Dianne M. Parrotte's net worth?

The estimated net worth of Dianne M. Parrotte is at least $442,827.00 as of August 7th, 2024. Dr. Parrotte owns 11,340 shares of Cognex stock worth more than $442,827 as of November 21st. This net worth evaluation does not reflect any other investments that Dr. Parrotte may own. Learn More about Dianne M. Parrotte's net worth.

How do I contact Dianne M. Parrotte?

The corporate mailing address for Dr. Parrotte and other Cognex executives is ONE VISION DRIVE, NATICK MA, 01760. Cognex can also be reached via phone at (508) 650-3000 and via email at [email protected]. Learn More on Dianne M. Parrotte's contact information.

Has Dianne M. Parrotte been buying or selling shares of Cognex?

Dianne M. Parrotte has not been actively trading shares of Cognex in the last ninety days. Most recently, on Wednesday, August 7th, Dianne M. Parrotte bought 2,000 shares of Cognex stock. The stock was acquired at an average cost of $38.62 per share, with a total value of $77,240.00. Following the completion of the transaction, the director now directly owns 11,340 shares of the company's stock, valued at $437,950.80. Learn More on Dianne M. Parrotte's trading history.

Who are Cognex's active insiders?

Cognex's insider roster includes Patrick Alias (Director), Eugene Banucci (Director), Sheila Dipalma (EVP), Dennis Fehr (SVP & CFO), Carl Gerst (EVP), Theodor Krantz (Director), Dianne Parrotte (Director), Jerry Schneider (Director), Anthony Sun (Director), Paul Todgham (CFO), and Robert Willett (CEO). Learn More on Cognex's active insiders.

Are insiders buying or selling shares of Cognex?

During the last twelve months, Cognex insiders bought shares 2 times. They purchased a total of 8,570 shares worth more than $327,162.80. During the last twelve months, insiders at the scientific and technical instruments company sold shares 1 times. They sold a total of 6,782 shares worth more than $274,942.28. The most recent insider tranaction occured on September, 4th when CFO Dennis Fehr bought 6,570 shares worth more than $249,922.80. Insiders at Cognex own 1.3% of the company. Learn More about insider trades at Cognex.

Information on this page was last updated on 9/4/2024.

Dianne M. Parrotte Insider Trading History at Cognex

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/7/2024Buy2,000$38.62$77,240.0011,340View SEC Filing Icon  
5/12/2022Buy3,000$46.00$138,000.003,608View SEC Filing Icon  
6/1/2021Sell333$80.03$26,649.99333View SEC Filing Icon  
2/19/2021Sell9,800$87.06$853,188.004,600View SEC Filing Icon  
8/28/2020Sell7,500$67.86$508,950.0020,200View SEC Filing Icon  
8/12/2020Sell7,500$66.49$498,675.0020,200View SEC Filing Icon  
8/13/2019Sell900$45.00$40,500.0019,700View SEC Filing Icon  
See Full Table

Dianne M. Parrotte Buying and Selling Activity at Cognex

This chart shows Dianne M Parrotte's buying and selling at Cognex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cognex Company Overview

Cognex logo
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to automotive, logistics, consumer electronics, medical-related, semiconductor, consumer products, food and beverage, and others, as well as through a network of distributors and integrators. The company was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Read More

Today's Range

Now: $39.05
Low: $38.18
High: $39.24

50 Day Range

MA: $39.90
Low: $38.30
High: $43.05

2 Week Range

Now: $39.05
Low: $34.79
High: $53.13

Volume

1,162,647 shs

Average Volume

1,273,980 shs

Market Capitalization

$6.70 billion

P/E Ratio

75.10

Dividend Yield

0.81%

Beta

1.4